Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial. Silvain, Johanne; Lattuca, Benoit; Beygui, Farzin; Rangé, Grégoire; Motovska, Zuzana; Dillinger, Jean-Guillaume; Boueri, Ziad; Brunel, Philippe; Lhermusier, Thibault; Pouillot, Christophe; Larrieu-Ardilouze, Elisa; Boccara, Franck; Labeque, Jean-Noël; Guedeney, Paul; El Kasty, Mohamad; Laredo, Mikael; Dumaine, Raphaëlle; Ducrocq, Grégory; Collet, Jean-Philippe; Cayla, Guillaume; Blanchart, Katrien; Kala, Petr; Vicaut, Eric; Montalescot, Gilles; ALPHEUS investigators. Lancet (London, England). 2020; 396: p.1737-1744. doi:10.1016/S0140-6736(20)32236-4Article
Épidémiologie clinique